JavaScript isn't enabled in your browser, so this file can't be opened. Enable and reload.
How to Succeed in a Transformational Med Tech Landscape: Regulatory, Evidence, and Communication Strategies Symposium
Please take the time to answer this short survey in order to help us put together content that will be most valuable to you during our symposium.
Sign in to Google
to save your progress.
Learn more
* Indicates required question
What is your email address?
*
Your answer
Which of the following do you perceive as key challenges facing the medical device industry in the next 3-5 years? (Please select your top 3)
Complexity of regulatory approval
Need for innovation in Research & Development
Long time-to-market (i.e. from R&D to launch)
Increasing cost of manufacturing & distribution
Obtaining reimbursement from payer organizations
Navigating complexity (i.e. COVID-19, digital health trends, technology trends, competitive environment, etc.) for strategic planning
Optimizing commercialization strategy, including marketing to patients & providers
Retaining in-house talent
Increased competition from other medical device companies
Increased competition from other industries (i.e. big tech, wearables, etc.)
In 2022, which of the following areas are you looking to increase investment in as part of your strategic & budget planning processes? (Choose all that apply)
Research & Development
Regulatory Affairs
Marketing
Market Access
Sales
Innovation (i.e. innovation challenges, hubs, partnerships, etc.)
What do you find most challenging with Medical Device Regulation (MDR) or In Vitro Diagnostic Regulation (IVDR)?
Your answer
What tools does your field force deem the most helpful in negotiating/obtaining pull through for devices for HCP stakeholders? (Choose all that apply)
Budget impact models
Reprints of clinical data
Real-world evidence studies/slide decks
Patient testimonials
HCP testimonials
Interactive content
Digital content platforms
Digital engagement
Traditional in-person field visits
Other:
What tools does your field force deem the most helpful in negotiating coverage & reimbursement for devices for payer HCP stakeholders? (Choose all that apply)
Budget impact models
Reprints of clinical data
Real-world evidence studies/slide decks
Patient testimonials
HCP testimonials
Interactive content
Digital content platforms
Digital engagement
Traditional in-person field visits
Other:
How many of your brands utilize customized digital stakeholder interactive tools, while engaging payers, in order to meet the growing payer need and preference for this type of interaction
Low 1/3 of the company’s brands (payer and HEOR teams)
Medium >1/3 but < 2/3 of the company’s brands (payer and HEOR teams)
High >2/3 of the company’s brands (payer and HEOR teams)
Unsure
Clear selection
How has your digital stakeholder engagement strategy evolved to cover the white space of numerous local payers where face to face interactions are limited
Remote interactive content is utilized with advanced analytics
We do not have digital stakeholder engagement tools or content for engaging local and regional white space
We have digital content, but no real plan or strategy to drive interactivity
Unsure
Clear selection
What percentage of your overall market access budget is allocated to digital engagement with payer stakeholders?
*
Your answer
Submit
Page 1 of 1
Clear form
Never submit passwords through Google Forms.
This content is neither created nor endorsed by Google.
Report Abuse
-
Terms of Service
-
Privacy Policy
Forms
